September 23, 2021
According to the recent research report titled ‘Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) - Analysis By Application, Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’, available with Market Study Report LLC, global chloromethyl isopropyl carbonate (CMIC) market was remunerated at USD 26.67 million in 2020 and is expected to grow considerably over 2021-2026.
Surging product demand from the pharmaceutical industry is primarily driving global chloromethyl isopropyl carbonate (CMIC) market growth, cites the study.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3958915/
For the unversed, chloromethyl isopropyl carbonate is a well-known pharmaceutical intermediate or specialty chemical used in the production of drugs to combat the AIDS virus and other diseases such as Hepatitis B. In fact, it is an important component of the Hepatitis-curing medicine Tenofovir.
There are various compounds utilized in the production of anti-retroviral. During the COVID-19 pandemic, consumption of antiviral medicines increased, resulting in a favorable scenario for producers of raw material of these drugs, such as companies producing CMIC and other compounds required in antiviral drug manufacturing.
Based on application spectrum, worldwide chloromethyl isopropyl carbonate (CMIC) market is split into hepatitis B virus intermediates, human immunodeficiency virus intermediates, and others. As per type, the industry segmentation is comprised of purity 98% and others.
Coming to geographical ambit, North America, Asia Pacific, and Europe are the top contributors to the overall industry remuneration. The report states that Asia Pacific currently holds considerable market share, owing to surging demand for antiviral drugs due to booming geriatric population susceptible to viral diseases.
Supportive regulatory policies and initiatives taken by the government are also swaying the regional market dynamics. Also, private organizations and government are heavily investing in this field in economies like India and China, encouraging new market entrants.
Major companies defining the competitive landscape of global chloromethyl isopropyl carbonate (CMIC) market sphere are Pingyuan Xinda Chemical Co., Ltd., Santa Cruz Biotechnology Inc., Anshul Specialty Molecules Pvt. Ltd., Atul Ltd., Paushak Ltd., and Chemcon Speciality Chemicals Ltd.